Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806334 · ClinicalTrials.gov registry record · NA
Radiogenomics of Muscle Invasive Bladder Cancer
A NA study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04806334: Clinical Trial NA study, sponsored by Cedars-Sinai Medical Center.
NCT04806334 is a NA study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04806334, a NA study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Patients with suspected bladder tumor will undergo novel 4D MRI imaging along with single cell RNA sequencing in hopes of identifying a radiogenomic signature that can improve our staging of patients with muscle invasive bladder cancer.
Primary Outcome
Number of participants who proceed with radiogenomics analysis with useable data, that is a preliminary signature related to MIBC.
Interventions
- DIAGNOSTIC_TEST MRI imaging of the pelvis/bladder
- DIAGNOSTIC_TEST genomic analysis of tumor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-03-02 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
Why NCT04806334 stopped before completion
NCT04806334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which MRI imaging of the pelvis/bladder is the first listed.
NCT04806334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04806334 about?
NCT04806334 is a clinical study titled "Radiogenomics of Muscle Invasive Bladder Cancer". Patients with suspected bladder tumor will undergo novel 4D MRI imaging along with single cell RNA sequencing in hopes of identifying a radiogenomic signature that can improve our staging of patients with muscle invasive bladder cancer.
What is the current status of trial NCT04806334?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2021-03-02. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT04806334?
The interventions under investigation include: MRI imaging of the pelvis/bladder (DIAGNOSTIC_TEST), genomic analysis of tumor (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04806334?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04806334's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI